These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35917744)

  • 1. First-line immunotherapy of neuronal surface antibody-mediated autoimmune encephalitis: Assessment of therapeutic effectiveness and cost-efficiency.
    Cai MT; Lai QL; Zheng Y; Fang GL; Shen CH; Xu YF; Zhang YX; Ding MP
    Mult Scler Relat Disord; 2022 Oct; 66():104071. PubMed ID: 35917744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
    Li TR; Zhang YD; Wang Q; Shao XQ; Li ZM; Lv RJ
    BMC Neurosci; 2020 Mar; 21(1):13. PubMed ID: 32228575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of intravenous immunoglobulin versus intravenous methylprednisolone treatment in anti-N-methyl-d-aspartate receptor encephalitis.
    Gong X; Luo R; Liu J; Guo K; Li A; Liu X; Liu Y; Zhou D; Hong Z
    Eur J Neurol; 2022 Apr; 29(4):1117-1127. PubMed ID: 34918418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.
    Nobile-Orazio E; Cocito D; Jann S; Uncini A; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Cavaletti G; Giannini F; Sabatelli M; Beghi E;
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):729-34. PubMed ID: 25246645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: Successful treatment of an anti-D2R and DPPX antibody-associated autoimmune encephalitis patient with high-dose methylprednisolone and intravenous immunoglobulin.
    Lin Z; Zhou F; Ni L; Dong S; Fu G; Zhao J
    Front Immunol; 2024; 15():1338714. PubMed ID: 38469308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
    Chan H; Chi H; You H; Wang M; Zhang G; Yang H; Li Q
    BMC Pediatr; 2019 May; 19(1):158. PubMed ID: 31101091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis.
    Wang J; Lin J; Wang M; Meng Z; Zhou D; Li J
    Front Immunol; 2021; 12():774664. PubMed ID: 34975861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis.
    Hoff LS; de Souza FHC; Miossi R; Shinjo SK
    Rheumatology (Oxford); 2022 Apr; 61(4):1579-1588. PubMed ID: 34302454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune encephalitis and immune therapy: lessons from Argentina.
    Melamud LI; Fernández VC; Manin A; Villa AM
    Acta Neurol Belg; 2020 Jun; 120(3):565-572. PubMed ID: 30182259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis.
    Lee ST; Lee HS; Lee WJ; Cha HA; Kim SH; Shin SY; Chu K; Lee SK
    Ann Clin Transl Neurol; 2022 May; 9(5):610-621. PubMed ID: 35315247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).
    Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F;
    Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study.
    Adrichem ME; Bus SR; Wieske L; Mohammed H; Verhamme C; Hadden R; van Schaik IN; Eftimov F
    Eur J Neurol; 2020 Mar; 27(3):506-513. PubMed ID: 31571349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis.
    Jang Y; Lee ST; Kim TJ; Jun JS; Moon J; Jung KH; Park KI; Chu K; Lee SK
    Sci Rep; 2018 Jan; 8(1):1012. PubMed ID: 29343812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with immunoadsorption therapy in four patients with severe and refractory anti-N-methyl-D-aspartate receptor encephalitis.
    Yang Y; Zhang B; Li M; Li J
    J Clin Apher; 2021 Dec; 36(6):886-892. PubMed ID: 34520046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
    Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; ; Anlar B; Armangue T; Benseler S; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sartori S; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK
    JAMA Neurol; 2021 Nov; 78(11):1333-1344. PubMed ID: 34542573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
    Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tacrolimus as long-term immunotherapy for neuronal surface antibody-mediated autoimmune encephalitis.
    Liu C; Ji S; Gao H; Bi Z; Zhang Q; Shang K; Cao J; Bu B
    Ther Adv Chronic Dis; 2022; 13():20406223211063055. PubMed ID: 35035868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy.
    Toledano M; Britton JW; McKeon A; Shin C; Lennon VA; Quek AM; So E; Worrell GA; Cascino GD; Klein CJ; Lagerlund TD; Wirrell EC; Nickels KC; Pittock SJ
    Neurology; 2014 May; 82(18):1578-86. PubMed ID: 24706013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review.
    DeSena AD; Noland DK; Matevosyan K; King K; Phillips L; Qureshi SS; Greenberg BM; Graves D
    J Clin Apher; 2015 Aug; 30(4):212-6. PubMed ID: 25664728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.